Author:
Sacu Seda,Slattery Catherine F.,Friston Karl J.,Paterson Ross W.,Foulkes Alexander J.M.,Yong Keir,Crutch Sebastian,Schott Jonathan M.,Razi Adeel
Abstract
AbstractLate-onset Alzheimer’s disease is consistently associated with alterations in the default-mode network (DMN)—a large-scale brain network associated with self-related processing and memory. However, the functional organization of DMN is far less clear in young-onset Alzheimer’s disease (YOAD). We assessed resting-state DMN effective connectivity in two common YOAD variants (i.e., amnestic variant (n = 26) and posterior cortical atrophy (n = 13) and healthy participants (n=24) to identify disease- and variant-specific connectivity differences using spectral dynamic causal modelling. Patients with the amnestic variant showed increased connectivity from prefrontal cortex to posterior DMN nodes relative to healthy controls, whereas patients with posterior cortical atrophy exhibited decreased posterior DMN connectivity. Right hippocampus connectivity differentiated the two patient groups. Furthermore, disease-related connectivity alterations were also predictive of group membership and cognitive performance. These findings suggest that resting-state DMN effective connectivity provides a new understanding of neural mechanisms underlying the disease pathology and cognition in YOAD.
Publisher
Cold Spring Harbor Laboratory
Reference70 articles.
1. Mendez, M. F . Early-onset Alzheimer disease and its variants. CONTINUUM Lifelong Learning in Neurology vol. 25 (2019).
2. Sirkis, D. W. , Bonham, L. W. , Johnson, T. P. , La Joie, R. & Yokoyama, J. S . Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. Molecular Psychiatry vol. 27 (2022).
3. Touroutoglou, A. et al. The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort. Alzheimer’s and Dementia vol. 19 (2023).
4. Graff-Radford, J. et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. The Lancet Neurology vol. 20 (2021).
5. Warren, J. D. , Fletcher, P. D. & Golden, H. L . The paradox of syndromic diversity in Alzheimer disease. Nature Reviews Neurology vol. 8 (2012).